Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
2019155 citationsJournal Articlebronze Open Access
Field-Weighted Citation Impact: 12.56
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension | Researchclopedia